Pharmaceutical company stock surges by 6% following announcement of a 30% year-over-year rise in net profit
Pharmaceutical company: One of the small-cap stocks involved in pharmaceuticals, consumer products, medical devices, protective devices, animal welfare, and food industries has experienced a surge of 5.92 percent following a 29.79 percent year-over-year increase in net profit.
Stock Price Movement
During Friday’s trading session, TTK Healthcare Limited’s shares rose to an intraday high of 5.92 percent from the previous close of Rs. 1,317. The current trading price is Rs. 1,340, with a high of Rs. 1,395 and a low of Rs. 1,301. The market capitalization now stands at approximately Rs. 1,893.46 crore.
Q3 FY25 Result Overview
In the latest quarterly results of TTK Healthcare Limited, the company’s consolidated revenue from operations increased by 11.36 percent year-over-year, from Rs. 183.85 crore in Q3 FY24 to Rs. 204.74 crore in Q3 FY25, and grew by 3.15 percent quarter-over-quarter from Rs. 198.49 crore in Q2 FY25.
The company saw revenue growth in various sectors, including animal welfare by 16.03 percent, consumer products by 29 percent, medical devices by 10.48 percent, protective devices by 29 percent, foods by 15.47 percent, and other operating income by 0.03 percent in Q3 FY25.
In Q3 FY25, TTK Healthcare Limited’s consolidated net profit increased by 29.79 percent year-over-year, reaching Rs. 16.73 crore compared to Rs. 12.89 crore during the same period last year. However, there was a 2.81 percent decrease in net profit compared to Q2 FY25, from Rs. 17.20 crore.
The basic earnings per share increased by 29.68 percent, standing at Rs. 11.84 compared to Rs.
For more market insights, follow our blog.
Stay tuned for more updates and insights on the stock market! For more insights on investing in the Indian stock market, check out resource like ET, NSE India.
Disclaimer: This blog post is for informational purposes only and should not be considered financial advice. Investors should conduct thorough research and consult with a qualified financial advisor before making any investment decisions.